Clinical deterioration during neutropenia recovery after G-CSF therapy in patient with COVID-19.

Conclusion: We observed a faster neutropenia recovery than previously known after administration of G-CSF in our case and in three similar cases previously reported in literature. This rapid neutropenia recovery and the robust inflammatory response in COVID-19 raise concerns about G-CSF safety in patients with COVID-19.
PMID: 32999856 [PubMed]

Source: Respiratory Care - October 3, 2020 Category: Respiratory Medicine Authors: Taha M, Sharma A, Soubani A Tags: Respir Med Case Rep Source Type: research